| . | Overall (n = 80) . | Medical (Group A; n = 33) . | TEVAR (Group B; n = 32) . | Open surgery (Group C; n = 15) . |
|---|---|---|---|---|
| Age (years; median; IQR) | 63 (55–69) | 65 (58.5–71.5) | 62 (54–67.5) | 61 (54.0–66.0) |
| Female | 21 (26.3%) | 7 (21.2%) | 9 (28.1%) | 5 (33.3%) |
| Hypertension | 79 (98.8%) | 32 (97.0%) | 32 (100%) | 15 (100%) |
| CHD | 17 (21.3%) | 9 (27.3%) | 6 (18.8%) | 2 (13.3%) |
| Marfan’s syndrome | 4 (5.0%) | 2 (6.1%) | 0 (0.0%) | 2 (13.3%) |
| COPD | 16 (20.0%) | 7 (21.2%) | 7 (21.9%) | 2 (13.3%) |
| IDDM | 16 (20.0%) | 7 (21.2%) | 9 (28.1%) | 0 (0.0%) |
| Obesity (BMI ≥ 30) | 33 (41.3%) | 9 (27.3%) | 18 (56.3%) | 6 (40.0%) |
| Renal insufficiency | 28 (35.0%) | 11 (33.3%) | 13 (40.6%) | 4 (26.7%) |
| Previous neurological dysfunction | ||||
| Paraplegia | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Stroke | 8 (10.0%) | 4 (12.1%) | 2 (6.2%) | 2 (13.4%) |
| Complicated dissection | 37 (46.3%) | 3 (9.1%)* | 19 (59.4%) | 15 (100%) |
| Aortic size (mm; median; IQR) | 48.0 (40.0–58.0) | 45 (36.5–50.5) | 44.5 (39.0–54.0) | 59.0 (53.0–60)*** |
| Aneurysma | 53 (66.2%) | 18 (54.5%) | 21 (65.6%) | 14 (93.3%)** |
| Thrombosis of false lumen (number of patients) | ||||
| Partial | 31 (38.8%) | 16 (48.5.3%) | 9 (28.1%) | 6 (40.0%) |
| Complete | 12 (15.0%) | 5 (15.2%) | 6 (18.8%) | 1 (6.7%) |
| Previous cardio-aortic surgery | 22 (27.5%) | (36.4%) | 6 (18.8%) | 4 (26.7%) |
| . | Overall (n = 80) . | Medical (Group A; n = 33) . | TEVAR (Group B; n = 32) . | Open surgery (Group C; n = 15) . |
|---|---|---|---|---|
| Age (years; median; IQR) | 63 (55–69) | 65 (58.5–71.5) | 62 (54–67.5) | 61 (54.0–66.0) |
| Female | 21 (26.3%) | 7 (21.2%) | 9 (28.1%) | 5 (33.3%) |
| Hypertension | 79 (98.8%) | 32 (97.0%) | 32 (100%) | 15 (100%) |
| CHD | 17 (21.3%) | 9 (27.3%) | 6 (18.8%) | 2 (13.3%) |
| Marfan’s syndrome | 4 (5.0%) | 2 (6.1%) | 0 (0.0%) | 2 (13.3%) |
| COPD | 16 (20.0%) | 7 (21.2%) | 7 (21.9%) | 2 (13.3%) |
| IDDM | 16 (20.0%) | 7 (21.2%) | 9 (28.1%) | 0 (0.0%) |
| Obesity (BMI ≥ 30) | 33 (41.3%) | 9 (27.3%) | 18 (56.3%) | 6 (40.0%) |
| Renal insufficiency | 28 (35.0%) | 11 (33.3%) | 13 (40.6%) | 4 (26.7%) |
| Previous neurological dysfunction | ||||
| Paraplegia | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Stroke | 8 (10.0%) | 4 (12.1%) | 2 (6.2%) | 2 (13.4%) |
| Complicated dissection | 37 (46.3%) | 3 (9.1%)* | 19 (59.4%) | 15 (100%) |
| Aortic size (mm; median; IQR) | 48.0 (40.0–58.0) | 45 (36.5–50.5) | 44.5 (39.0–54.0) | 59.0 (53.0–60)*** |
| Aneurysma | 53 (66.2%) | 18 (54.5%) | 21 (65.6%) | 14 (93.3%)** |
| Thrombosis of false lumen (number of patients) | ||||
| Partial | 31 (38.8%) | 16 (48.5.3%) | 9 (28.1%) | 6 (40.0%) |
| Complete | 12 (15.0%) | 5 (15.2%) | 6 (18.8%) | 1 (6.7%) |
| Previous cardio-aortic surgery | 22 (27.5%) | (36.4%) | 6 (18.8%) | 4 (26.7%) |
*P < 0.01; **P < 0.05 and ***P ≤ 0.02.
| . | Overall (n = 80) . | Medical (Group A; n = 33) . | TEVAR (Group B; n = 32) . | Open surgery (Group C; n = 15) . |
|---|---|---|---|---|
| Age (years; median; IQR) | 63 (55–69) | 65 (58.5–71.5) | 62 (54–67.5) | 61 (54.0–66.0) |
| Female | 21 (26.3%) | 7 (21.2%) | 9 (28.1%) | 5 (33.3%) |
| Hypertension | 79 (98.8%) | 32 (97.0%) | 32 (100%) | 15 (100%) |
| CHD | 17 (21.3%) | 9 (27.3%) | 6 (18.8%) | 2 (13.3%) |
| Marfan’s syndrome | 4 (5.0%) | 2 (6.1%) | 0 (0.0%) | 2 (13.3%) |
| COPD | 16 (20.0%) | 7 (21.2%) | 7 (21.9%) | 2 (13.3%) |
| IDDM | 16 (20.0%) | 7 (21.2%) | 9 (28.1%) | 0 (0.0%) |
| Obesity (BMI ≥ 30) | 33 (41.3%) | 9 (27.3%) | 18 (56.3%) | 6 (40.0%) |
| Renal insufficiency | 28 (35.0%) | 11 (33.3%) | 13 (40.6%) | 4 (26.7%) |
| Previous neurological dysfunction | ||||
| Paraplegia | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Stroke | 8 (10.0%) | 4 (12.1%) | 2 (6.2%) | 2 (13.4%) |
| Complicated dissection | 37 (46.3%) | 3 (9.1%)* | 19 (59.4%) | 15 (100%) |
| Aortic size (mm; median; IQR) | 48.0 (40.0–58.0) | 45 (36.5–50.5) | 44.5 (39.0–54.0) | 59.0 (53.0–60)*** |
| Aneurysma | 53 (66.2%) | 18 (54.5%) | 21 (65.6%) | 14 (93.3%)** |
| Thrombosis of false lumen (number of patients) | ||||
| Partial | 31 (38.8%) | 16 (48.5.3%) | 9 (28.1%) | 6 (40.0%) |
| Complete | 12 (15.0%) | 5 (15.2%) | 6 (18.8%) | 1 (6.7%) |
| Previous cardio-aortic surgery | 22 (27.5%) | (36.4%) | 6 (18.8%) | 4 (26.7%) |
| . | Overall (n = 80) . | Medical (Group A; n = 33) . | TEVAR (Group B; n = 32) . | Open surgery (Group C; n = 15) . |
|---|---|---|---|---|
| Age (years; median; IQR) | 63 (55–69) | 65 (58.5–71.5) | 62 (54–67.5) | 61 (54.0–66.0) |
| Female | 21 (26.3%) | 7 (21.2%) | 9 (28.1%) | 5 (33.3%) |
| Hypertension | 79 (98.8%) | 32 (97.0%) | 32 (100%) | 15 (100%) |
| CHD | 17 (21.3%) | 9 (27.3%) | 6 (18.8%) | 2 (13.3%) |
| Marfan’s syndrome | 4 (5.0%) | 2 (6.1%) | 0 (0.0%) | 2 (13.3%) |
| COPD | 16 (20.0%) | 7 (21.2%) | 7 (21.9%) | 2 (13.3%) |
| IDDM | 16 (20.0%) | 7 (21.2%) | 9 (28.1%) | 0 (0.0%) |
| Obesity (BMI ≥ 30) | 33 (41.3%) | 9 (27.3%) | 18 (56.3%) | 6 (40.0%) |
| Renal insufficiency | 28 (35.0%) | 11 (33.3%) | 13 (40.6%) | 4 (26.7%) |
| Previous neurological dysfunction | ||||
| Paraplegia | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Stroke | 8 (10.0%) | 4 (12.1%) | 2 (6.2%) | 2 (13.4%) |
| Complicated dissection | 37 (46.3%) | 3 (9.1%)* | 19 (59.4%) | 15 (100%) |
| Aortic size (mm; median; IQR) | 48.0 (40.0–58.0) | 45 (36.5–50.5) | 44.5 (39.0–54.0) | 59.0 (53.0–60)*** |
| Aneurysma | 53 (66.2%) | 18 (54.5%) | 21 (65.6%) | 14 (93.3%)** |
| Thrombosis of false lumen (number of patients) | ||||
| Partial | 31 (38.8%) | 16 (48.5.3%) | 9 (28.1%) | 6 (40.0%) |
| Complete | 12 (15.0%) | 5 (15.2%) | 6 (18.8%) | 1 (6.7%) |
| Previous cardio-aortic surgery | 22 (27.5%) | (36.4%) | 6 (18.8%) | 4 (26.7%) |
*P < 0.01; **P < 0.05 and ***P ≤ 0.02.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
